Lumentum Holdings Inc.'s executive vice president, Vincent Retort, has been active in recent stock transactions. Mr. Retort, who serves as Executive Vice President of Module Business Unit R&D and Product Development at Lumentum, completed two notable sales of the company's common stock.
On May 18, 2026, Mr. Retort sold a total of 3,183 shares of common stock. The value realized from this sale amounted to $3,036,422, with each share transacted at a price of $953.95. This specific transaction was carried out under the framework of a Rule 10b5-1 trading plan, which Mr. Retort had originally established on November 13, 2025.
A second disposal occurred slightly earlier, on May 15, 2026. On this date, Mr. Retort disposed of 3,299 shares of Lumentum common stock, totaling $3,202,339. The sale price for these shares was set at $970.70 per share. These particular shares were withheld by Lumentum Holdings Inc. to fulfill necessary income tax withholding and remittance obligations related to the vesting of restricted stock units.
Following both of these reported sales transactions, Mr. Retort's direct holdings in Lumentum Holdings Inc.'s common stock amount to 89,563 shares. This current total includes an additional 70 shares that he acquired through participation in the company's Employee Stock Purchase Plan on May 15, 2026.
Beyond the insider trading activity, Lumentum Holdings Inc. has also reported several significant corporate developments. The company announced its Q3 FY2026 earnings, which surpassed analyst expectations. Specifically, Lumentum posted an earnings per share (EPS) of $2.37, exceeding the forecasted figure of $2.26. Furthermore, the financial results showed revenue reaching $808.4 million, slightly surpassing the expected revenue projection of $802.94 million.
The company's market profile is set for a major change, as Lumentum announced its addition to the Nasdaq-100 Index prior to the market open on May 18, 2026. This inclusion represents a notable milestone because the index tracks the 100 largest non-financial companies listed on the Nasdaq stock exchange.
In separate analyst coverage, BofA Securities updated its valuation of Lumentum. The firm increased its price target for Lumentum to $1,100 from its previous level of $775, citing what it described as an improved margin outlook. Additionally, BofA raised its estimates for the company's earnings in both fiscal 2026 and fiscal 2027. These increases were quantified at 18% and 9%, respectively.
Despite these positive developments, BofA maintained a Neutral rating on Lumentum shares. These recent updates provide investors with important insights into the company's current financial performance metrics and its evolving market standing within the broader indices.
Risks
- The article notes that despite the positive financial reports and index inclusion, BofA Securities maintained a Neutral rating on Lumentum shares.
- Insider selling activity by Executive Vice President Vincent Retort occurred during this period (May 18, 2026, and May 15, 2026).
More from Insider Trading
Risks
- The article notes that despite the positive financial reports and index inclusion, BofA Securities maintained a Neutral rating on Lumentum shares.
- Insider selling activity by Executive Vice President Vincent Retort occurred during this period (May 18, 2026, and May 15, 2026).